Revance Therapeutics Inc

Company Snapshot
1222 Demonbreun Street
Nashville, TN 37203
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 534
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
$10,556,000
$54,388,000
$80,898,000
Operating Income
($273,162,000)
($274,676,000)
($272,169,000)
Net Income
($282,089,000)
($281,310,000)
($356,422,000)
2020
Gross Profit
$10,556,000
Operating Income
($273,162,000)
Net Income
($282,089,000)
2021
Gross Profit
$54,388,000
Operating Income
($274,676,000)
Net Income
($281,310,000)
2022
Gross Profit
$80,898,000
Operating Income
($272,169,000)
Net Income
($356,422,000)
The above data on Revance Therapeutics Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Director and Chief Executive Officer
$1,314,070
$5,278,215
$14,631
$6,606,916
$6,606,916
Director and Chief Executive Officer
President
$880,790
$1,680,781
$30,878
$2,592,449
$2,592,449
President
Chief Financial Officer and Principal Accounting Officer
$741,219
$1,526,147
$12,465
$2,279,831
$2,279,831
Chief Financial Officer and Principal Accounting Officer
Senior Vice President General Counsel and Corporate Secretary
$729,879
$1,526,147
$13,895
$2,269,921
$2,269,921
Senior Vice President General Counsel and Corporate Secretary
Independent Director
$80,000
$219,510
$0
$299,510
$299,510
Independent Director
Revance Therapeutics Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us